• IDEAYA Biosciences priced a USD 300 million underwritten follow-on offering of common stock and pre-funded warrants.
• Deal includes 5,555,556 common shares at USD 27 per share.
• Also selling pre-funded warrants for 5,555,576 shares at USD 27 per warrant; exercise price USD 0.0001 per share.
• Underwriters hold a 30-day option to buy up to 1,666,669 additional common shares at the offering price.
• Closing expected on or about June 10, 2026, subject to customary conditions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IDEAYA Biosciences Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202606082222PR_NEWS_USPR_____SF79048) on June 09, 2026, and is solely responsible for the information contained therein.